Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Hope Coalition: HCQ and Lopinavir/Ritonavir for COVID-19
NCT04403100Phase 3Unknown
- Sponsor
- CardResearch
- Start
- Jun 2020
- Primary completion
- Feb 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine, lopinavir, ritonavir in coronavirus disease 2019 (COVID-19), sponsored by CardResearch. Status: unknown.
02
Drugs
hydroxychloroquinelopinavirritonavir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04403100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04403100.